|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 38/18 |
| (11) | Number of the document | 2970493 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14768797.4 |
| Date of filing the European patent application | 2014-02-26 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/018743 |
| Date | 2014-02-26 |
| (87) | Number | WO 2014/149477 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361800102 P | 2013-03-15 | US |
| (72) |
WILLINGHAM, Stephen, US
HOWARD, Maureen, US
LIU, Jie, US
MAJETI, Ravindra, US
PROHASKA, Susan Sweeney, US
VOLKMER, Anne K., US
VOLKMER, Jens-Peter, US
WEISSMAN, Irving L., US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170, 3rd Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | METHODS FOR ACHIEVING THERAPEUTICALLY EFFECTIVE DOSES OF ANTI-CD47 AGENTS |
| METHODS FOR ACHIEVING THERAPEUTICALLY EFFECTIVE DOSES OF ANTI-CD47 AGENTS |